top of page

CHO-K1/Human PAC1 Stable Cell

Item
Cat#
Price

Stable Cell Line

SNB-G-0229A

$19,800

Compound Testing Services

CT-001

$1,850 per 384w plate

(Up To 16 cpds Dose)



Product Description


The PAC1 receptor (pituitary adenylate cyclase-activating polypeptide type 1 receptor) is a class B G protein-coupled receptor encoded by the ADCYAP1R1 gene, with high selectivity for its endogenous ligands PACAP-27 and PACAP-38. It is primarily distributed in the central nervous system (e.g., hypothalamus, hippocampus, cerebellum, brainstem) and peripheral tissues (adrenal medulla, pancreas, testis, lungs, and immune cells). Its core function involves activating Gs and Gq proteins to stimulate cAMP production and calcium mobilization, thereby mediating neurotransmission regulation, neuroprotection, promotion of neuronal survival and synaptic plasticity, while also participating in hormone secretion, inflammatory responses, and vasodilation regulation. This receptor plays critical roles in migraine, post-traumatic stress disorder, and neurodegenerative diseases.

 

Screeningbio’s CHO-K1/Human PAC1 cell line overexpress ADCYAP1R1 and is designed to detect increases in intracellular cAMP levels or IP-1 levels in response to agonist stimulation of the receptor. Cisbio HTRF cAMP kit or IP-1 kit can be used to detect the signal.

Product Specifications

Target Type

GPCR

Species

Human

HGNC Symbol

ADCYAP1R1

Accession Number

NM_001118

Parental Line

CHO-K1

Lot#

See Vial

Storage

Liquid Nitrogen


Data

CHO-K1/Human PAC1 Agonist Assay. CHO-K1/Human PAC1 cells were treated with the reference agonist. The assay was run based on Revvity cAMP HTRF protocol. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 values were determined, using GraphPad Prism software.
CHO-K1/Human PAC1 Agonist Assay. CHO-K1/Human PAC1 cells were treated with the reference agonist. The assay was run based on Revvity cAMP HTRF protocol. Non-linear regression was used to plot activity changes vs. [Compound, M], and EC50 values were determined, using GraphPad Prism software.


Target Background


The PAC1 receptor (pituitary adenylate cyclase-activating polypeptide type 1 receptor) is a class B G protein-coupled receptor encoded by the ADCYAP1R1 gene, with high selectivity for its endogenous ligands PACAP-27 and PACAP-38.


It is primarily distributed in the central nervous system (e.g., hypothalamus, hippocampus, cerebellum, brainstem) and peripheral tissues (adrenal medulla, pancreas, testis, lungs, and immune cells). Its core function involves activating Gs and Gq proteins to stimulate cAMP production and calcium mobilization, thereby mediating neurotransmission regulation, neuroprotection, promotion of neuronal survival and synaptic plasticity, while also participating in hormone secretion, inflammatory responses, and vasodilation regulation.


This receptor plays critical roles in migraine, post-traumatic stress disorder, and neurodegenerative diseases.

Product Documentation



Screeningbio

For research use only. All rights reserved. Not for use in diagnostic procedures, human or veterinary treatment, food, cosmetics, or household applications. ScreeningBio provides laboratory research products and R&D services to qualified research organizations. We do not sell pharmaceuticals, dietary supplements, or products intended for human consumption.

6181 Cornerstone Ct, Suite 102, San Diego, CA 92121, USA

Quick Links

Connect

  • Facebook
  • Twitter
  • LinkedIn

CHINA: 上海格宁生物

info@screeningbio.com

4th Floor, Building 24, No.1188 Lianhang Road Minhang District, Shanghai, China

bottom of page